E. E. Feygina

Detection of Neprilysin-Derived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure.

A. G. Semenov, A. Postnikov, Natalia N. Tamm, 2019, Clinical chemistry.

Searching for a BNP standard: Glycosylated proBNP as a common calibrator enables improved comparability of commercial BNP immunoassays.

A. G. Semenov, F. Apple, S. Love, 2017, Clinical biochemistry.

Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.

A. G. Semenov, Alexander G Semenov, Evgeniya E Feygina, 2018, Advances in clinical chemistry.

Characterization of endogenously circulating IGFBP-4 fragments-Novel biomarkers for cardiac risk assessment.

S. Kozlovsky, D. V. Serebryanaya, A. Postnikov, 2015, Clinical biochemistry.

Neutral Endopeptidase (Neprilysin) in Therapy and Diagnostics: Yin and Yang

A. G. Semenov, A. Katrukha, E. E. Feygina, 2019, Biochemistry (Moscow).

Diagnostic utility of total NT-proBNP testing by immunoassay based on antibodies targeting glycosylation-free regions of NT-proBNP

A. G. Semenov, E. E. Feygina, Zhenlu Zhang, 2022, Clinical chemistry and laboratory medicine.